Clinical Trial Update: Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix Porcine Circovirus (PCV)-Free Liquid Compared to Rotarix Liquid Given in 2-doses in Healthy Chinese Infants Starting at Age 6-16 Weeks [Phase 3]

View source ↗

Summary

Phase 3 trial comparing immunogenicity, reactogenicity, and safety of Rotarix PCV-free liquid to Rotarix liquid in healthy Chinese infants; results posted in Ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteritis

Drugs mentioned

• Rotarix PCV-free liquid (Rotavirus vaccine, live attenuated)
• Rotarix liquid (Rotavirus vaccine, live attenuated)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Gastroenteritis | Phase 3 | Status: COMPLETED | Results posted: 2025-05-09